Also published in the New England Journal of Medicine in 2022, the SURMOUNT-1 trial demonstrated that tirzepatide at the 15 mg dose produced an average weight loss of 22.5% of body weight over 72 weeks approaching results typically seen with bariatric surgery (Jastreboff et al., 2022, PMID: 35658024)
About the practical aspects: "What is the titration schedule, and how quickly will we increase the dose?" "How should I handle injection technique and site selection ?" "What is the best time of day to take this medication?" "How should I store the medication ?" "What happens if I miss a dose or need to adjust timing ?" Practical questions demonstrate that you are already thinking about adherence and implementation, not just acquisition
I dont have the scientific evidence to prove it (yet), but as I look at the extreme side effects many people experience (nausea, fainting, pancreatitis, dampening reward systems, gas, etc.) its clear to me that the drugs are fighting the natural order of how our bodies function and I have major concerns for how this will impact us in ways we dont yet see
doi: 10.3389/fgene.2019.00514 17 GiordanoATommonaroG